FIELD: medicine.
SUBSTANCE: technique involves venous blood sampling with preparing blood serum samples. The prepared samples are analysed by tray enzyme immunoassay EIA to measure an amount of neopterin NP, tumour necrosis factor TNF-α, interleukin-6 IL-6, vascular endothelial growth factor VEGF, matrix metalloproteinases MMP-2 and MMP-9, tissue inhibitor of matrix metalloproteinase-1 TIMP-1. The measured values are analysed and used to calculate coefficient K by formula: If K≤15.8, a benign process is diagnosed, whereas K>15.8 shows a malignant process.
EFFECT: using this technique enables improving specificity and information value of bone tissue neoplasm diagnosis and makes it possible to determine the neoplasm nature by preoperative minimally invasive procedure to optimise a patient surveillance, correcting a surgical technique and admitting to special care medical institutions taking into account a level of complexity of planned manipulations.
2 ex
Title | Year | Author | Number |
---|---|---|---|
DIAGNOSTIC TECHNIQUE FOR BENIGN AND MALIGNANT OSSEOUS GROWTHS | 2013 |
|
RU2522223C1 |
DIAGNOSTIC TECHNIQUE FOR BONE TUMOURS | 2011 |
|
RU2454665C1 |
METHOD OF QUALITATIVE DIFFERENTIAL EXPRESS-DIAGNOSTICS OF LIP MUCOSA NEOPLASMS BY CONTENT OF BIOMARKERS IN PATIENT'S ORAL FLUID | 2013 |
|
RU2535076C1 |
QUALITATIVE DIFFERENTIAL INSTANT DIAGNOSTIC TECHNIQUE FOR PAROTID GLAND GROWTHS SHOWN BY PATIENT'S ORAL FLUID BIOMARKERS | 2013 |
|
RU2527676C1 |
QUALITATIVE DIFFERENTIAL INSTANT DIAGNOSTIC TECHNIQUE FOR NEW GROWTHS OF ORAL FLOOR MUCOSA SHOWN BY PATIENT'S ORAL FLUID BIOMARKERS | 2013 |
|
RU2533241C1 |
QUALITATIVE DIFFERENTIAL INSTANT DIAGNOSTIC TECHNIQUE FOR PERIGLOTTIS GROWTHS SHOWN BY PATIENT'S ORAL FLUID BIOMARKERS | 2013 |
|
RU2533248C1 |
METHOD OF EVALUATING STATE OF THE PATIENT'S KIDNEY FOR THE PRESENCE OF CANCER | 2015 |
|
RU2607954C1 |
METHOD FOR DIAGNOSING BREAST CANCER AND OVARIAN CANCER BY MMP-9 MRNA LEVEL IN BLOOD PLASMA | 2020 |
|
RU2745424C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS AND PROGNOSIS OF ENDOMETRIUM MYOMA AND CANCER | 2010 |
|
RU2430371C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF BUCCAL MUCOSA FORMATION BY THE CONTENT OF BIOMARKERS IN THE PATIENT'S ORAL FLUID | 2022 |
|
RU2782093C1 |
Authors
Dates
2015-12-10—Published
2014-12-16—Filed